It’s known for connecting “privacy-safe AI-generated audiences” for healthcare marketing. And, it’s just announced a strategic partnership with the nation’s largest audio content creation and distribution company.
The pact between Swoop and iHeartMedia makes the Real Chemistry business arm’s custom patient audiences available for broadcast radio planning, activation and measurement.
“Pharmaceutical and life sciences companies can now leverage the same brand-exclusive Swoop segments they already use for digital activation to better inform media planning across iHeartMedia’s ad-enabled broadcast radio portfolio,” the companies say.
Swoop is one of iHeartMedia’s preferred healthcare data providers, and its capabilities enable healthcare marketers to move from legacy age and gender buying to data-driven broadcast radio activation in an ad-enabled portfolio.
“By applying privacy-safe machine learning and artificial intelligence to a real world data universe of more than 300 million de-identified patient journeys and 65 billion anonymous social determinants of health signals, Swoop develops audiences specifically designed for a brand’s unique objectives and a treatment’s core therapeutic advantages,” the company notes.
Brian Kaminsky, who serves as Chief Data Officer and President of Revenue Strategies at iHeartMedia, commented, “iHeartMedia has been leading the way in data driven media planning and delivery for all forms of audio including streaming, podcast and broadcast radio. Our goal is to make sure we’re getting our client’s messages to the right listeners and driving results. Our partnership with Swoop, and their pharmaceutical industry-leading audience segments, powers up our ability to fulfill that promise for healthcare marketers who are struggling to find the combination of reach and audience targeting that only iHeartMedia’s combined audio platforms which includes the massive scale of broadcast radio can provide.”
Swoop has built more than 3,000 exclusive privacy-safe patient segments for 42 of the top 50 pharmaceutical brands and 18 of the top 20 healthcare marketing agencies. Audiences are built against each client’s unique ideal patient definitions and brand objectives, and audience quality is independently verified by a third party prior to activation, providing full performance transparency. It is the first consumer health data company to become a member of the Network Advertising Initiative (NAI) and assures 100% compliance with the NAI 2020 Code of Conduct Guidelines, making its segments approved for common, specialty and rare conditions, both sensitive and non-sensitive in nature.
